Free tool
Oncology stocks
We cover 24 companies grouped under the Oncology theme. The median market value in the group is $19.03M. Across the group, the median move over the past trading day is 0.00%. 42% of the 24 with a 200-day average trade above it. Price change over the past year runs from −57.8% to +65.6% across the middle 80 percent of the group, with a median of −10.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
24 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| OSE.PA | OSE Immunotherapeutics SA | $88.75M | Micro cap | −47.94% |
| POLB.L | Poolbeg Pharma PLC | $82.41M | Micro cap | +164.62% |
| SAR.L | Sareum Holdings plc | $70.10M | Micro cap | +76.19% |
| MAAT.PA | MaaT Pharma SA | $65.60M | Micro cap | −33.91% |
| CANTA.ST | Cantargia AB (publ) | $51.16M | Micro cap | −27.38% |
| COIL.L | Coiled Therapeutics plc | $49.30M | Micro cap | −26.92% |
| SVE.WA | Synthaverse S.A. | $47.18M | Micro cap | −36.25% |
| MOC.WA | Molecure S.A. | $41.03M | Micro cap | −22.39% |
| NNG.WA | NanoGroup S.A. | $28.00M | Micro cap | −17.36% |
| DEX.ST | Dextech Medical AB | $20.09M | Micro cap | +26.38% |
| ALTME.PA | TME Pharma N.V. | $17.97M | Micro cap | +25.97% |
| ABERA.ST | Abera Bioscience AB | $17.69M | Micro cap | +1.61% |
| B8FK.DE | Biofrontera AG | $17.36M | Micro cap | −3.07% |
| ACTI.ST | Active Biotech AB (publ) | $14.50M | Micro cap | −62.00% |
| CRTX.L | CRISM Therapeutics Corporation | $12.38M | Micro cap | +9.52% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | $7.05M | Micro cap | −19.44% |
| CHOSA.ST | Chosa Oncology AB | $7.01M | Micro cap | −9.00% |
| NFX.L | Nuformix plc | $5.85M | Micro cap | +80.68% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | $3.53M | Micro cap | +11.79% |
| VAL.L | ValiRx plc | $2.78M | Micro cap | −73.04% |
| ATORX.ST | Alligator Bioscience AB (publ) | $1.88M | Micro cap | −99.27% |
| PTP.DE | Pentixapharm Holding AG | $1.06M | Micro cap | +5.47% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.